drugset / Trial / NCT00418522

This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus

NCT00418522

Phase 4 Completed 413 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is to determine if inhaled insulin is effective in treating type 2 diabetes mellitus.

Timeline

Start
2007-03
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 1 mg Inhaled
Comparator insulin glargine Protein / enzyme biologic 10 unknown